Narazaki M - Search Results

1

Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.

Breen EC, Gage JR, Guo B, Magpantay L, Narazaki M, Kishimoto T, Miles S, Martínez-Maza O. Breen EC, et al. Among authors: narazaki m. Cell Immunol. 2001 Sep 15;212(2):118-25. doi: 10.1006/cimm.2001.1852. Cell Immunol. 2001. PMID: 11748928

2

Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.

Aoki Y, Narazaki M, Kishimoto T, Tosato G. Aoki Y, et al. Among authors: narazaki m. Blood. 2001 Nov 15;98(10):3042-9. doi: 10.1182/blood.v98.10.3042. Blood. 2001. PMID: 11698289 Free article.

3

The molecular biology of interleukin 6 and its receptor.

Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M, Taga T. Kishimoto T, et al. Among authors: narazaki m. Ciba Found Symp. 1992;167:5-16; discussion 16-23. doi: 10.1002/9780470514269.ch2. Ciba Found Symp. 1992. PMID: 1425018 Review.

4

Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.

Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T. Yasukawa K, et al. Among authors: narazaki m. Immunol Lett. 1992 Feb;31(2):123-30. doi: 10.1016/0165-2478(92)90138-e. Immunol Lett. 1992. PMID: 1740350

5

Interleukin-6 family of cytokines and gp130.

Kishimoto T, Akira S, Narazaki M, Taga T. Kishimoto T, et al. Among authors: narazaki m. Blood. 1995 Aug 15;86(4):1243-54. Blood. 1995. PMID: 7632928 Free article. Review. No abstract available.

6

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.

Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T. Narazaki M, et al. Blood. 1993 Aug 15;82(4):1120-6. Blood. 1993. PMID: 8353278 Free article.

7

Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6.

Lee IS, Liu Y, Narazaki M, Hibi M, Kishimoto T, Taga T. Lee IS, et al. Among authors: narazaki m. FEBS Lett. 1997 Jan 20;401(2-3):133-7. doi: 10.1016/s0014-5793(96)01456-1. FEBS Lett. 1997. PMID: 9013873 Free article.

8

Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal.

Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T, Kishimoto T. Suzuki H, et al. Among authors: narazaki m. Eur J Immunol. 1993 May;23(5):1078-82. doi: 10.1002/eji.1830230515. Eur J Immunol. 1993. PMID: 8477802

9

A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

Tanaka T, Narazaki M, Ogata A, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Semin Immunol. 2014 Feb;26(1):88-96. doi: 10.1016/j.smim.2014.01.009. Epub 2014 Mar 1. Semin Immunol. 2014. PMID: 24594001 Review.

10

The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Narazaki M, Kishimoto T. Narazaki M, et al. Int J Mol Sci. 2018 Nov 9;19(11):3528. doi: 10.3390/ijms19113528. Int J Mol Sci. 2018. PMID: 30423923 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters